UK markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1100+0.0500 (+4.72%)
At close: 04:00PM EDT
1.1300 +0.02 (+1.80%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0600
Bid1.1200 x 27000
Ask1.1300 x 27000
Day's range1.0520 - 1.1100
52-week range1.0400 - 4.3500
Avg. volume6,315,725
Market cap339.925M
Beta (5Y monthly)2.32
PE ratio (TTM)N/A
EPS (TTM)-0.4800
Earnings date03 May 2023 - 08 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.10
  • Motley Fool

    Buy This Magnificent Growth Stock Before It's Too Late

    Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr.

  • Motley Fool

    Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript

    Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO)Q4 2022 Earnings CallMar 09, 2023, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to the Bionano fourth-quarter and full-year 2022 earnings conference call.

  • Zacks

    Bionano Genomics, Inc. (BNGO) Reports Q4 Loss, Misses Revenue Estimates

    Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -44.44% and 0.32%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?